Atomwise CEO and co-founder Abraham Heifets (left) and co-founder Izhar Wallach
A couple billion for Exscientia was only part of Sanofi's AI ambitions, as the Big Pharma adds Atomwise to the table
Sanofi made clear its AI ambitions were real at the beginning of this year when the Big Pharma took its drug discovery collaboration with Exscientia …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
